Newspapers in July 2015 were filled with reports about second-line chemotherapy impairing the quality of the last week of life for cancer patients. The basis of the reports was the multicenter CwC1 (Coping with Cancer 1) study that associated impaired quality of death (QOD) with prior administration of second-line chemotherapy.1 These reports are misleading because although there are many reasons not to administer toxic and
APRIL 29, 2016